{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:14:25Z","timestamp":1788509665864,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["68787"],"award-info":[{"award-number":["68787"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.TBZMED.REC.1400.1065"],"award-info":[{"award-number":["IR.TBZMED.REC.1400.1065"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xphs.2026.104285","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:07:38Z","timestamp":1776294458000},"page":"104285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fe\u00b2\u207a-activated reactive oxygen species amplification via metal-organic frameworks loaded with paclitaxel for enhanced radiosensitivity in breast cancer radiotherapy"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8245-7789","authenticated-orcid":false,"given":"Zohreh","family":"Daliri Sosefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2857-1454","authenticated-orcid":false,"given":"Motahareh","family":"Khoshkar Foshtomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Jalili J","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-9847","authenticated-orcid":false,"given":"Ali Reza","family":"Farajollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.xphs.2026.104285_bib0002","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2217\/nnm-2018-0347","article-title":"Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy","volume":"14","author":"He","year":"2019","journal-title":"Nanomedicine"},{"issue":"32","key":"10.1016\/j.xphs.2026.104285_bib0003","doi-asserted-by":"crossref","first-page":"11045","DOI":"10.1039\/D0DT01882A","article-title":"Recent advances in MOF-based nanoplatforms generating reactive species for chemodynamic therapy","volume":"49","author":"Zhong","year":"2020","journal-title":"Dalton Trans"},{"issue":"4","key":"10.1016\/j.xphs.2026.104285_bib0004","first-page":"330","article-title":"Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer","volume":"2","author":"Kwatra","year":"2013","journal-title":"Transl Cancer Res"},{"issue":"49","key":"10.1016\/j.xphs.2026.104285_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904329","article-title":"Advanced nanotechnology leading the way to multimodal imaging-guided precision surgical therapy","volume":"31","author":"Wang","year":"2019","journal-title":"Adv Mater"},{"issue":"3","key":"10.1016\/j.xphs.2026.104285_bib0006","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1021\/acsnano.9b07898","article-title":"Full-process radiosensitization based on nanoscale metal\u2013organic frameworks","volume":"14","author":"Gong","year":"2020","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.xphs.2026.104285_bib0007","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamadermatol.2017.2176","article-title":"Identifying an optimal adjuvant radiotherapy dose for extremity and trunk merkel cell carcinoma following resection: an analysis of the National cancer database","volume":"153","author":"Patel","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13566-016-0281-4","article-title":"Radiosurgery for brainstem metastases with and without whole brain radiotherapy: clinical series and literature review","volume":"6","author":"Murray","year":"2017","journal-title":"J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0009","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/10717544.2017.1378939","article-title":"Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine","volume":"24","author":"Jiang","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2026.104285_bib0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2015.12.012","article-title":"Gold nanoparticles for applications in cancer radiotherapy: mechanisms and recent advancements","volume":"109","author":"Her","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"29","key":"10.1016\/j.xphs.2026.104285_bib0011","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1039\/C9SC02107H","article-title":"Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy","volume":"10","author":"Zhang","year":"2019","journal-title":"Chem Sci"},{"issue":"32","key":"10.1016\/j.xphs.2026.104285_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201700996","article-title":"Emerging nanotechnology and advanced materials for cancer radiation therapy","volume":"29","author":"Song","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.xphs.2026.104285_bib0013","series-title":"Nanotechnology-Based Precision Tools for the Detection and Treatment of Cancer","first-page":"151","article-title":"Radiosensitization and nanoparticles","author":"Paunesku","year":"2015"},{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0014","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2013.04.004","article-title":"The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-concept","volume":"108","author":"Mirjolet","year":"2013","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104285_bib0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1078-0432.CCR-16-1297","article-title":"First-in-human study testing a new radioenhancer using nanoparticles (NBTXR3) activated by radiation therapy in patients with locally advanced soft tissue sarcomas","volume":"23","author":"Bonvalot","year":"2017","journal-title":"Clinic Cancer Res"},{"issue":"8","key":"10.1016\/j.xphs.2026.104285_bib0016","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S1470-2045(19)30326-2","article-title":"NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc): a multicentre, phase 2\u20133, randomised, controlled trial","volume":"20","author":"Bonvalot","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.xphs.2026.104285_bib0017","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7150\/thno.11642","article-title":"Nanoparticles for radiation therapy enhancement: the key parameters","volume":"5","author":"Retif","year":"2015","journal-title":"Theranostics"},{"issue":"46","key":"10.1016\/j.xphs.2026.104285_bib0018","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"10.1016\/j.xphs.2026.104285_bib0019","first-page":"776","article-title":"Nanoparticle formulations of cisplatin for cancer therapy","volume":"8","author":"Duan","year":"2016","journal-title":"Wiley Interdiscip Rev"},{"issue":"11","key":"10.1016\/j.xphs.2026.104285_bib0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.xphs.2026.104285_bib0021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.addr.2016.05.021","article-title":"Radiation effects on the tumor microenvironment: implications for nanomedicine delivery","volume":"109","author":"Stapleton","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2026.104285_bib0022","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fchem.2020.00225","article-title":"Enhanced tumor targeting and radiotherapy by quercetin loaded biomimetic nanoparticles","volume":"8","author":"Huang","year":"2020","journal-title":"Front Chem"},{"issue":"8","key":"10.1016\/j.xphs.2026.104285_bib0023","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41551-018-0203-4","article-title":"Low-dose X-ray radiotherapy\u2013radiodynamic therapy via nanoscale metal\u2013organic frameworks enhances checkpoint blockade immunotherapy","volume":"2","author":"Lu","year":"2018","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0024","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1038\/s41467-018-06655-7","article-title":"Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy","volume":"9","author":"Ni","year":"2018","journal-title":"Nat Commun"},{"issue":"37","key":"10.1016\/j.xphs.2026.104285_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201800202","article-title":"Metal\u2013organic framework nanoparticles","volume":"30","author":"Wang","year":"2018","journal-title":"Adv Mater"},{"issue":"22","key":"10.1016\/j.xphs.2026.104285_bib0026","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1039\/C9SC00747D","article-title":"Catalase-like metal\u2013organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence","volume":"10","author":"Chen","year":"2019","journal-title":"Chem Sci"},{"issue":"14","key":"10.1016\/j.xphs.2026.104285_bib0027","doi-asserted-by":"crossref","first-page":"12021","DOI":"10.1021\/acsomega.2c00223","article-title":"Hafnium-based metal\u2013organic framework nanoparticles as a radiosensitizer to improve radiotherapy efficacy in esophageal cancer","volume":"7","author":"Zhou","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0028","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41467-018-04703-w","article-title":"Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy","volume":"9","author":"Ni","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.xphs.2026.104285_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120642","article-title":"D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy","volume":"269","author":"Du","year":"2021","journal-title":"Biomaterials"},{"issue":"39","key":"10.1016\/j.xphs.2026.104285_bib0030","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1039\/D0TB01616K","article-title":"Highly stable and biocompatible hyaluronic acid-rehabilitated nanoscale MOF-Fe 2+ induced ferroptosis in breast cancer cells","volume":"8","author":"Xu","year":"2020","journal-title":"J Mater Chem B"},{"issue":"5","key":"10.1016\/j.xphs.2026.104285_bib0031","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1021\/acsanm.0c00581","article-title":"FePt nanoparticles embedded in metal\u2013Organic framework nanoparticles for tumor imaging and eradication","volume":"3","author":"Meng","year":"2020","journal-title":"ACS Appl Nano Mater"},{"issue":"26","key":"10.1016\/j.xphs.2026.104285_bib0032","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1002\/ange.201902612","article-title":"A catalase-like metal-organic framework nanohybrid for O2-evolving synergistic chemoradiotherapy","volume":"131","author":"He","year":"2019","journal-title":"Angew Chem"},{"issue":"8","key":"10.1016\/j.xphs.2026.104285_bib0033","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1166\/mex.2020.1813","article-title":"Encapsulating doxorubicin in PEGylation metal-organic frameworks for combined radiation therapy in liver cancer treatment","volume":"10","author":"Liu","year":"2020","journal-title":"Mater Express"},{"issue":"4","key":"10.1016\/j.xphs.2026.104285_bib0034","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1021\/acsnano.8b09221","article-title":"Quercetin-modified metal\u2013organic frameworks for dual sensitization of radiotherapy in tumor tissues by inhibiting the carbonic anhydrase IX","volume":"13","author":"Ma","year":"2019","journal-title":"ACS Nano"},{"issue":"24","key":"10.1016\/j.xphs.2026.104285_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201901156","article-title":"Synergistic amplification of oxidative stress\u2013Mediated antitumor activity via liposomal dichloroacetic acid and MOF-Fe2+","volume":"15","author":"Sun","year":"2019","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.xphs.2026.104285_bib0036","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2231-4040.82950","article-title":"Nanosuspension: an approach to enhance solubility of drugs","volume":"2","author":"Patel","year":"2011","journal-title":"J Adv Pharm Technol Res"},{"issue":"35","key":"10.1016\/j.xphs.2026.104285_bib0037","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1021\/ja306869j","article-title":"Yolk\u2013shell nanocrystal@ ZIF-8 nanostructures for gas-phase heterogeneous catalysis with selectivity control","volume":"134","author":"Kuo","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.xphs.2026.104285_bib0038","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10934-017-0498-7","article-title":"Iron doped zeolitic imidazolate framework (Fe-ZIF-8): synthesis and photocatalytic degradation of RDB dye in Fe-ZIF-8","volume":"25","author":"Thanh","year":"2018","journal-title":"J Porous Mater"},{"issue":"12","key":"10.1016\/j.xphs.2026.104285_bib0039","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/nano10122490","article-title":"Dissolution enhancement and controlled release of paclitaxel drug via a hybrid nanocarrier based on MPEG-PCL amphiphilic copolymer and Fe-BTC porous metal-organic framework","volume":"10","author":"Bikiaris","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.xphs.2026.104285_bib0040","series-title":"Introduction to Spectroscopy","author":"Pavia","year":"2015"},{"issue":"25","key":"10.1016\/j.xphs.2026.104285_bib0041","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1039\/c2ra21087h","article-title":"Cytotoxicity and slow release of the anti-cancer drug doxorubicin from ZIF-8","volume":"2","author":"Vasconcelos","year":"2012","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104285_bib0042","series-title":"2022 29th National and 7th International Iranian Conference on Biomedical Engineering (ICBME)","first-page":"273","article-title":"Fabrication of MIL-100 (Fe) metal-organic framework nanocarrier for the controlled release of Paclitaxel against MCF-7 breast cancer cells","author":"Razavi","year":"2022"},{"key":"10.1016\/j.xphs.2026.104285_bib0043","series-title":"Characterization of Porous Solids and Powders: Surface area, Pore Size and Density","author":"Lowell","year":"2012"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104285_bib0044","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2017.02.008","article-title":"Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting","volume":"520","author":"Ghorbani","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104285_bib0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.msec.2016.06.007","article-title":"A novel dual-responsive core-crosslinked magnetic-gold nanogel for triggered drug release","volume":"68","author":"Ghorbani","year":"2016","journal-title":"Mater Sci Eng C"},{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801526","article-title":"Metal\u2013organic framework-based stimuli-responsive systems for drug delivery","volume":"6","author":"Cai","year":"2019","journal-title":"Adv Sci"},{"key":"10.1016\/j.xphs.2026.104285_bib0047","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2020.10.069","article-title":"Rational design of metal-organic frameworks to deliver methotrexate for targeted rheumatoid arthritis therapy","volume":"330","author":"Guo","year":"2021","journal-title":"J Controll Rel"},{"issue":"6","key":"10.1016\/j.xphs.2026.104285_bib0048","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1039\/D0NJ05105E","article-title":"A novel pH-responsive Fe-MOF system for enhanced cancer treatment mediated by the Fenton reaction","volume":"45","author":"Wang","year":"2021","journal-title":"New J Chem"},{"issue":"3","key":"10.1016\/j.xphs.2026.104285_bib0049","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1039\/C3TB20832J","article-title":"Cytotoxicity of nanoscaled metal\u2013organic frameworks","volume":"2","author":"Tamames-Tabar","year":"2014","journal-title":"J Mater Chem B"},{"issue":"4","key":"10.1016\/j.xphs.2026.104285_bib0050","doi-asserted-by":"crossref","DOI":"10.1088\/2053-1591\/abed89","article-title":"Construction of the targeted and pH-sensitive paclitaxel drug delivery system RGD\/PTX@ ZIF-90 and anti-tumor activity research","volume":"8","author":"Ge","year":"2021","journal-title":"Mater Res Express"},{"issue":"6","key":"10.1016\/j.xphs.2026.104285_bib0051","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnci\/86.6.441","article-title":"In vitro studies of Taxol as a radiation sensitizer in human tumor cells","volume":"86","author":"Liebmann","year":"1994","journal-title":"JNCI"},{"issue":"1","key":"10.1016\/j.xphs.2026.104285_bib0052","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2710.2007.00796.x","article-title":"The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells","volume":"32","author":"Jin","year":"2007","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.xphs.2026.104285_bib0053","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cmdc.201900596","article-title":"Highly porous hybrid metal\u2013organic nanoparticles loaded with gemcitabine monophosphate: a multimodal approach to improve chemo-and radiotherapy","volume":"15","author":"Li","year":"2020","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.xphs.2026.104285_bib0054","doi-asserted-by":"crossref","first-page":"02TR01","DOI":"10.1088\/1361-6560\/aa99ce","article-title":"Nanoparticle radio-enhancement: principles, progress and application to cancer treatment","volume":"63","author":"Kuncic","year":"2018","journal-title":"Phys Med Biol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:36:25Z","timestamp":1788507385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022354926001346"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104285","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fe\u00b2\u207a-activated reactive oxygen species amplification via metal-organic frameworks loaded with paclitaxel for enhanced radiosensitivity in breast cancer radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104285"}}